| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP0824534B1 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 07/31/2002 | EP0755398B1 Process for the resolution of etodolac using glucamine derivatives |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361774A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/31/2002 | CN1361663A Fungicidal combinations of active substances |
| 07/31/2002 | CN1361107A Method of obtaining dewatered fugutoxin |
| 07/31/2002 | CN1088460C Process for isolating galanthamine |
| 07/31/2002 | CN1088457C Photochromic naphthopyran compounds |
| 07/31/2002 | CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema |
| 07/30/2002 | US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives |
| 07/25/2002 | WO2002057270A1 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057264A1 Pyrrole derivates for treating cytokine mediated diseases |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057216A1 Terphenyl compounds bearing substituted amino groups |
| 07/25/2002 | WO2002056885A1 Camptothecin derivatives |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 07/25/2002 | WO2001090091A8 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/25/2002 | US20020099226 Method of purifying tetrodotoxin |
| 07/25/2002 | US20020099070 Dihydronaphthyridine potassium channel openers |
| 07/25/2002 | US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/25/2002 | US20020099055 Novel compounds |
| 07/25/2002 | CA2435692A1 Pyrrole derivates for treating cytokine mediated diseases |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/24/2002 | EP1224182A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423707 Nitroimidazole ester analogues and therapeutic applications |
| 07/18/2002 | WO2002055524A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
| 07/18/2002 | WO2002020481A3 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
| 07/18/2002 | WO2001083480A3 Dihydropyridine compounds and methods of use |
| 07/18/2002 | US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
| 07/18/2002 | US20020094978 Novel isoxazoline fibrinogen receptor antagonists |
| 07/18/2002 | US20020094977 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis |
| 07/18/2002 | US20020094936 Fungicidal activity |
| 07/18/2002 | CA2434005A1 Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP0901492B1 Taxane derivatives, the preparation thereof and formulations containing them |
| 07/17/2002 | EP0694035B1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420379 Alkynyl-substituted camptothecins and process for their preparation |
| 07/16/2002 | US6420372 Tropical malarial antiprotozoan |
| 07/16/2002 | US6420370 Pyrimidine derivatives and method of making and using derivatives |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2001017563A3 Integrin-mediated drug targeting |
| 07/11/2002 | US20020091256 2,3-dicyano-5-amino-5-hydroxy-6-phenylmethylidene-7-methyl-4H-1,4 -diazepine for example; electroluminescence; charge transfer agents; electroluminescence device |
| 07/11/2002 | US20020091151 Novel macrocycles and uses thereof |
| 07/11/2002 | US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | DE10100175A1 New thiazolyl-substituted pyranone or pyridone derivatives, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221439A1 Tetrahydroquinoline derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
| 07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1357548A Process for production of levo-ofloxacin |
| 07/10/2002 | CN1357547A Prepn. of levo-ofloxacin |
| 07/10/2002 | CN1357327A Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/10/2002 | CN1087296C Process for preparing tetrahydro-indolizines |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417202 3-acetyl-4-methyl-2,5-di(4-pyridyl)-1h-pyrrole, for example; treating cell adhesion molecules (cams) mediated diseases such as arthritis, aids, septic shock, cachexia, transplant rejection |
| 07/09/2002 | CA2244519C C-4":substituted macrolide antibiotics |
| 07/09/2002 | CA2041224C Azatetracycle compounds |
| 07/04/2002 | WO2002051883A1 Synthesis of novel heterocyclic molecules oxygenated by metathesis reaction on solid support using novel silylated linkers |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | US20020087010 Useful as photochromic compounds; covalently attached to wang resins and method of attaching; ophthalmic lenses |
| 07/04/2002 | US20020086999 Certain quinoline derivatives |
| 07/04/2002 | US20020086997 Method of isolating anhydro-tetrodotoxin |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | DE10044649A1 Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine Substituted 4-phenyl-1- (1-phenylcyclohexyl) -1,2,3,6-tetrahydropyridines |
| 07/03/2002 | EP1219626A1 Compounds for fluorescence labeling |
| 07/03/2002 | EP1218349A2 Method for selectively dissociating cyclic carboxylic acid anhydrides |
| 07/03/2002 | EP1218348A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 07/03/2002 | EP1217994A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 07/03/2002 | EP0860433B1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same |
| 07/03/2002 | EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
| 07/03/2002 | CN1356104A Antalgic method by general medicine application |
| 07/02/2002 | US6414149 Treating diabetes, treating or preventing diabetic complications |
| 07/02/2002 | US6413977 Chromeno[4,3,2-DE]isoquinolines as potent dopamine receptor ligands |
| 06/27/2002 | WO2002050082A2 Inhibitors of papilloma virus |
| 06/27/2002 | WO2002050081A2 Antimicrobial agents |
| 06/27/2002 | WO2002050080A1 Small molecules useful in the treatment of inflammatory disease |
| 06/27/2002 | WO2002050071A1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |